Boundless Bio, Inc.

NASDAQ:BOLD

Biotechnology

Healthcare
$2.38 +85.71%

+$1.20 today

Market cap
$56.20M
Beta
0.97
P/E (TTM)
-1.0
EPS (TTM)
-$2.50
52W Low $0.96High $2.75

Volume 0.13M

Average 0.22M

Balance Sheet

Inspect the capital base behind the business.

Assets

$157.06M

FY 2025 · Annual

-23.9% YoY

Liabilities

$58.41M

FY 2025 · Annual

+4.7% YoY

Equity

$98.65M

FY 2025 · Annual

-34.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents34.29M10.95M23.71M26.59M17.87M
Short-term Investments38.74M55.77M97.05M125.53M89.71M
Net Receivables00000
Inventory00000
Other Current Assets1.54M1.32M3.45M2.28M2.03M
Total Current Assets74.57M68.04M124.2M154.39M109.61M
Property, Plant & Equipment (Net)3.1M7.73M4.58M51.36M46.88M
Goodwill00000
Intangible Assets00000
Long-term Investments34.99M0560K00
Tax Assets00000
Other Non-current Assets1.07M1.07M555K659K573K
Total Non-current Assets39.15M8.79M5.69M52.02M47.45M
Total Assets113.72M76.83M129.89M206.41M157.06M
Account Payables1.08M1.4M2.22M1.27M1.49M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.51M2.55M2.9M2.78M2.64M
Total Current Liabilities3.87M7.73M9.36M8.14M12.54M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities148.04M147.95M247.62M00
Total Non-current Liabilities148.04M150.8M247.62M47.63M45.87M
Total Liabilities151.91M158.53M256.98M55.77M58.41M
Common Stock2K2K02K2K
Retained Earnings(40.77M)(86.68M)(136.11M)(201.47M)(259.67M)
Accumulated OCI(175K)(398K)40K121K64K
Other Stockholders Equity002K00
Minority Interest00000
Total Equity(38.19M)(81.7M)(127.08M)150.64M98.65M
Total Debt377K5.18M2.2M47.63M49.04M
Net Debt(33.91M)(5.77M)(21.51M)21.05M31.17M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$17.5M
Short-term Investments$75.4M
Other Current$1.8M
Total Current Assets$94.6M
PP&E (Net)$45.8M
Other Non-current$583.0K
Total Non-current Assets$46.4M
Total Assets$141.0M

Analysis

Selected assets total $141.0M for Latest. The largest visible component is Short-term Investments at $75.4M, about 53.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipNov 10, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
EFFECTEFFECT filingNov 3, 2026
424B3424B3 filingNov 3, 2026

How much cash does BOLD have?

Boundless Bio, Inc. (BOLD) reported $17.87M in cash and equivalents in fiscal 2025.

How much debt does BOLD carry?

Boundless Bio, Inc. (BOLD) reported $49.03M of total debt, with net debt of $31.17M.